 |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
 |
 |
 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
 The Diagnostics team at FPG works with its clients to provide tailored, global advice on corporate strategic programs. Companies in this sector create products that play an important role in the diagnosis and in the selection of treatments for patients and are an integral part of modernized, high quality, cost-efficient patient care. The Diagnostics Industry seeks to answer these important questions: Q1. Are you sick? Q2. How sick are you? Q3. Where are you sick? Q4. How should you be treated? Q5. How effective is your treatment? Technological advances in the Diagnostics Industry will increase the role of diagnostics throughout the entire disease management process; i.e. identification, location (by imaging), treatment selection and monitoring of the effects of that treatment on the diseases. The treatment of disease used to be the exclusive domain of therapeutics; however, with advances in pharmacogenomic-based diagnostics, determining the patient's drug response will become the norm in many therapeutic sectors leading to the closer matching of therapeutic agents to the individual's medical needs. Similar tests will be used to screen out patients whose genetic profile may lead to an adverse reaction to a drug or to a class of drugs. Medical Diagnostics can be broken down into two large, and rather distinct categories: in vitro testing and in vivo testing. Diagnostic in vitro tests are those performed outside the body and are needed to answer Questions 1, 2, 4 and 5 above. Diagnostic in vivo testing (e.g. Diagnostic Imaging) products play a traditional role in locating and/or visualizing the disease (Question 3) and its current status (Question 2), and are being increasingly utilized in disease management of cancer, cardiology, and vascular disorders.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
